It would be hard to find a more challenging time for Michelle McMurry-Heath to join the Biotechnology Innovation Organization as its CEO given the COVID-19 pandemic and the protests over racial inequality in the US. But the organization is trying to rise to the occasion on both fronts, with biotech companies pioneering new responses to the pandemic and a new push on diversity and inclusion.
BIO recently unveiled its BIOEquality Agenda, which outlines goals for reducing systemic inequality, injustice and unfair treatment of women and minority groups. The organization aims to address disparities in health care, economic development, nutrition and environmental… Read more »
UNDERWRITERS AND PARTNERS
